Ácido úrico e Doença cardiovascular

Autores

  • Joana Guimarães Interna do Internato Complementar de Endocrinologia, Hospitais da Universidade de Coimbra, Coimbra, Portugal
  • Nuno Devesa Interno do Internato Complementar de Medicina Interna, Hospitais da Universidade de Coimbra, Coimbra, Portugal
  • Rita Reis Interna do Internato Complementar de Medicina Interna, Hospitais da Universidade de Coimbra, Coimbra, Portugal
  • Francisco Parente Assistente Graduado de Medicina Interna, Hospitais da Universidade de Coimbra, Coimbra, Portugal
  • Borges Alexandrino Assistente Graduado de Medicina Interna, Hospitais da Universidade de Coimbra, Coimbra, Portugal
  • José Júlio Moura Director do Serviço de Medicina II dos Hospitais da Universidade de Coimbra; Professor da Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal

Palavras-chave:

Ácido úrico, Doença Cardiovascular, Factor de risco

Resumo

O interesse no ácido úrico como um potencial
factor de risco de Doença Cardiovascular é
abordado em inúmeros artigos de revisão. Parece não haver dúvidas que o ácido úrico é um
factor de risco cardiovascular, ideia essa que
persiste desde há 50 anos. Contudo, a questão
central não é a sua associação com Doença
Cardiovascular, mas se desempenha um papel
causal no desenvolvimento de Doença Cardiovascular.
Tem sido difícil identifi car o papel específico
da hiperuricémia devido à sua associação
com outros factores de risco cardiovascular,
já estabelecidos, como Hipertensão, Diabetes Mellitus, Dislipidémia e Obesidade.
Um melhor conhecimento dos mecanismos patogénicos da hiperuricémia poderão esclarecer
a importância da elevação dos valores séricos de ácido úrico.

Downloads

Não há dados estatísticos.

Referências

Puig JG, Ruilope LM. Hiperuricemia como factor de riesgo cardiovascular. Med Clin (Barc) 2001;117:93-95;

Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Reappraisal of the Pathogenesis and Consequences of Hyperuricemia in Hypertension, Cardiovascular Disease, and Renal Disease. American Journal of Kidney Diseases 1999;33(2):225-234;

Waring WS, Webb DJ, Maxwell SRJ. Uric acid as a risk factor for cardiovascular disease. Q J Med 2000;93:707-713;

Culleton BF. Uric acid and cardiovascular disease: a renal-cardiac relationship? Curr Op in Nephrol and Hypertension 2001;10:371-375;

Jonhson RJ, Tuttle KR. Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in

cardiovascular disease. Hypertension 2000;35:E10;

Torun M, Yardim S, Sinsek B, Burgaz S. Serum uric acid levels in Cardiovascular Disease. J Clin Pharm Ther 1998;23:25-9;

Pattern RL, Hewitt D, Woldman GT, Jones G, Little JA. Associations of plasma high density lipoprotein cholesterol with clinical chemistry

data. Circulation 1980;62:IV31-IV41;

Tykarski A. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron

;59:364-8;

Selby JV, Friedman GD, Quesenberry CPJ. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990;131:1017-27;

Alderman MH, Cohen H, Madhavan S, Kivlighun S. Serum uric acid and Cardiovascular Events in Successfully treated hypertensive

patients. Hypertens 1999;34:144-50;

Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998;352:670-671;

Verdecchia P, Schillaci G, Reboldi GP, Santeusanio F, Porcellati C, Brunett P. Relation between serum uric acid and risk of Cardiovascular

Disease in Essential Hypertension. The PIUMA Study. Hypertension 2000;36:1072-1078;

Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Kiel U. Association of serum uric acid with all-cause and cardiovascular disease

mortality and incident myocardial enfarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999;10:391-7;

Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Daunhaurer A, Hofmann KP, Meyer J. Serum uric acid as an Independent Predictor

of Mortality in Patients with Angiographically Proven Coronary Artery Disease. Am J Cardiol 2002;89(1):12-17;

Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for Cardiovascular Disease and death: The Framingham Heart

Study. Ann Intern Med 1999;131:7-13;

Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997;78:147-53;

Moriarity JF, Folsom AR, Iribarrenc, et al. Serum uric acid and risk of coronary heart disease. Atherosclerosis risk in Communities (ARIC)

study. Ann Epidemiol 2000;10:136-143;

Dobson A. Is raised serum uric acid a cause of cardiovascular disease or death? The Lancet 1999;354:1578;

Reunanen A, Takkunen H, Knekt P, Aromaa A. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand 1982;668:49-

;

Goldberg RJ, Burchfi el CM, Benfante R, et al. Lifestyle and biologic factors associated with atherosclerotic disease in middle aged men:

year findings from the Honolulu Heart Program. Arch Intern Med 1995;155:686-694;

Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol

; 121:11-18;

Levine W, Dyer AR, Shekelle RB, et al. Serum uric acid and 11,5 year mortality of middle aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989;42:257-267;

Staessen J. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991;90:50-54;

Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease: The NHANES I

epidemiologic follow-up study. Am J Epidemiol 1995;141:637-644;

Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non insulin-dependent

diabetes mellitus. Stroke 1998;29:635-639;

Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow up study, 1971-1992. National

Health and Nutrition Examination Survey. JAMA 2000;283:2404-2410;

Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the

Elderly Program (SHEP). J Hypertens 2000;18:1149-1154;

Puig JG, Ruilope LM. Ácido úrico e hipertensión arterial. Med Clin 2000;114:34-38

Ficheiros Adicionais

Publicado

30-09-2004

Como Citar

1.
Guimarães J, Devesa N, Reis R, Parente F, Alexandrino B, Moura JJ. Ácido úrico e Doença cardiovascular. RPMI [Internet]. 30 de Setembro de 2004 [citado 30 de Maio de 2024];11(3):155-60. Disponível em: https://revista.spmi.pt/index.php/rpmi/article/view/1759

Edição

Secção

Artigos de Revisão

Artigos mais lidos do(s) mesmo(s) autor(es)

1 2 3 > >>